Mackenzie Financial
YARW

Mackenzie Financial’s Yarrow Bioscience YARW Stock Holding History

Mackenzie Financial’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed -$20.2K – 1620
2022
Q4 		$20.2K Hold
150
– – ﹤0.01% 1398
2022
Q3 		$30K Buy
150
+77
+105% +$24.6K ﹤0.01% 1392
2022
Q2 		$25K Hold
73
– – ﹤0.01% 1431
2022
Q1 		$42K Buy
+73
New +$43.4K ﹤0.01% 1376

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Mackenzie Financial's YARW Position: Q1 2023 in Review

Mackenzie Financial sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 150 shares — an estimated $20.2K sold.

Mackenzie Financial first reported a position in YARW in Q1 2022 and held it in 4 quarters. The position peaked at $42K in Q1 2022. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Mackenzie Financial reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Mackenzie Financial sold 150 Yarrow Bioscience shares in Q1 2023, an estimated $20.2K.
  • Mackenzie Financial first reported a position in Yarrow Bioscience in Q1 2022 and held it in 4 quarters.
  • Mackenzie Financial's Yarrow Bioscience position peaked at $42K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.